Lipid metabolism disturbances in children with chronic renal failure treated conservatively;Zaburzenia gospodarki lipidowej u dzieci chorych na przewlekł a̧ niewydolność nerek leczonych zachowawczo

Przeglad Pediatryczny

Volumn 34, Issue 1, 2004, Pages 46-51

  Puziewicz Zmonarska, Anna ^a   Zwolińska, Danuta ^a   Zmonarski, Sławomir Cezary ^a   Makulska, Irena ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Atheromatous indexes; Children; Chronic renal failure; Lipid metabolism

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHILD; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; INFANT; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; UREMIA;

EID: 3042698517     PISSN: 0137723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Attman P.O. Hyperlipoproteinaemia in renal failure: pathogenesis and perspectives for intervention. Neprol. Dial. Transpl., 1993, 8, 294-295.
2. Diop M.E., Viron B., Bailleul S., Lefevre G., Fessi H., Maury J., Etienne J. and Couderc R. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow study. Clin. Neph., 2000, 54, 3, 210-217.
3. Diop M.E., Viron B., Bailleul S., Lefevre G., Fessi H., Maury J., Etienne J. and Couderc R. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow study. Clin. Neph., 2000, 54, 3, 210-217.
4. Kasiske B.L. Hyperlipidemia in patients with chronic renal disease. Am. J. Kidney Dis., 1998, 32, 5, 142-156
5. Klin M. Zaburzenia gospodarki lipidowej u chorych na przewlekł a̧ niewydolność nerek i u chorych po przeszczepieniu nerki. Tyg. Lek., 1992, 47, 31-33
6. Cappelli P., Di Liberato L., Albertazzi A. Role of dyslipidemia in the progression of chronic renal disease. Ren. Fail., 1998, 20, 2, 391-7.
7. Diop M.E., Viron B., Bailleul S., Lefevre G., Fessi H., Maury J., Etienne J. and Couderc R. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow study. Clin. Neph., 2000, 54, 3, 210-217.
8. Attman P. O. Progression of renal failure and lipids- is there evidence for a link in humans? Nephrol. Dial. Transplant., 1998, 13, 545-547.
9. Attman P.O., Alaupovic P. Lipid and apolipoprotein profiles of uremic dys-lipoproteinemia- relation to renal function and dialysis. Nephron 1991; 657, 401-410.
10. Attman P.O., Samuelsson O., Alaupovic P. Progression of renal failure: role of apolipoprotein B-containing lipoproteins. Kidney Int., 1997, 52, 98-101.
11. Jȩdrzejowski A. Zaburzenia lipidowe u dzieci z niewydolnościa̧ nerek.- W: Matka i dziecko -postȩpy w neonatologii, i nefrologii dzieciȩcej, pod red. K. Karczewskiej, Warszawa 1999, 402-422.
12. Pejović M.D., Djordjević V.B., Savić V., Vlahović P. Cholesterol and triglyceride content in lipoprotein fractions of rats treated with bovine serum albumin. Nephron, 1996, 73, 713.
13. Singh A., Tejani A. Hyperlipidemia in children: the role of uremia, steroids and cyclosporine therapy. Nephron, 1996, 74, 529-535.
14. Grützmacher P., Marz W., Peschke B., Gross W., Schoeppe W. Lipoproteins and apolipoproteins during the progression of chronic renal disease. Nephron 1988, 50, 103-111.
15. Samuelsson O., Attman P. O., Knight-Gibson C., Kron B., Larsson R., Mulec H., Weiss L. and Alaupovic P. Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrol. Dial. Transplant., 1994, 9, 1580-1585.
16. Rajman I., Harper L., McPake D., Kendall M.J., Wheeler D.C. Low-density lipoprotein subfraction profiles in chronic renal failure. Nephrol. Dial. Transplant., 1998, 13 (9), 2281-2287.
17. Zdrojewski Z., Rutkowski B. W: Zaburzenia przemiany białkowej, wȩglowodanowej i lipidowej. Dializoterapia w codziennej praktyce. Red. Rutkowski B., MAKmed s.c., Gdańsk, 1996, 355-362.
18. Kimak E., Solski J., Janicka L. Liporotein profiles at different stages of chronic renal insufficiency. Ren. Fail., 2000, 22 (1), 63-71.
19. Milionis H.J., Elisaf M.S., Tselepis A., Bairaktari E., Karabina S.A., Siamopoulos K.C. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure. Am. J. Kidney Dis., 1999, 33 (6), 1100-1106.
20. Keane W.F., Martinez-Maldonado M. Lipids and progressive renal disease: the cardio- renal link. Am. J. Kidney Dis., 1999, 34 (2), 43-46.
21. Zwolińska D. Zaburzenia metabolizmu tlenowego u dzieci i młodzieży z przewlekła̧ niewydolnościa̧ nerek. Rozprawa habilitacyjna. Wrocław 1995.
22. Zwolińska D., Kiliś Pstrusińska K., Szprynger K. Lipoproteina (a) u dzieci z przewlekła̧ niewydolnoś cia̧ nerek leczonych zachowawczo. Polski Merkuriusz Lekarski 1997, 3 (15).
23. Zwolińska D., Szprynger K. Lipoproteina (a) u dzieci ze schyłkowa̧ niewydolnościa̧ nerek leczonych powtarzanymi hemodializami oraz cia̧gła̧ ambulatoryjna̧ dializa̧ otrzewnowa̧ Przegl. Lek. 1997, 54 (5), 320-323.
24. Samuelsson O., Attman P.O., Knight-Gibson C., Larsson R., Mulec H., Weiss L., Alaupovic P. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J. Am. Soc. Nephrol., 1998, 9 (8), 1482-1488.
25. Paragh G., Seres I., Balogh Z., Varga Z., Karpati I., Matyus J., Ujheyi L., Kakuk G. The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia. Nephron, 1998, 80 (2), 166-170.
26. Cappelli P., Di Liberato L., Albertazzi A. Role of dyslipidemia in the progression of chronic renal disease. Ren. Fail., 1998, 20 (2), 391-7.